Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

Becton, Dickinson and Company (BDX)

-NYSE
118.37 Down 0.12(0.10%) Jul 25, 4:02PM EDT
|After Hours : 118.37 0.00 (0.00%) Jul 25, 4:43PM EDT
ProfileGet Profile for:
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417
United States - Map
Phone: 201-847-6800
Website: http://www.bd.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:29,979

Business Summary 

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment produces medical devices that are used in various healthcare settings. This segment’s products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; and generic prefilled injectables. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment’s products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company’s BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment’s products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Key Statistics


Company Websites 
Home Page
Investor Relations
Employment
Subsidiaries
Search Yahoo! for:
More on Becton, Dickinson and Company

Corporate Governance 
Becton, Dickinson and Company’s ISS Governance QuickScore as of Jul 1, 2014 is 2. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Vincent A. Forlenza BD, 61
Chairman, Chief Exec. Officer and Pres
2.19M1.28M
Mr. Christopher R. Reidy , 57
Chief Financial Officer and Exec. VP of Admin.
282.00K0.00
Mr. William A. Kozy , 62
Chief Operating Officer and Exec. VP
1.59M759.00K
Mr. Jeffrey S. Sherman Esq., 59
Sr. VP and Gen. Counsel
1.09M1.11M
Mr. Gary M. Cohen , 55
Exec. VP
1.11M1.86M
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders